1. Editorial

   • Peter Josef Ell

   EditorialNotes Pages: 1369 - 1369

2. European board of nuclear medicine (EBNM): What is it for?

   • B. Bok

   Editorial Pages: 1370 - 1371

3. Techniques for measuring renal transit time

   • Charles D. Russell
   • M. Japanwalla
   • Eva V. Dubovsky

   Original article Pages: 1372 - 1378

4. Renal and extrarenal clearance of^99mTc-MAG₃: A comparison with¹²⁵I-OIH and⁵¹Cr-EDTA in patients representing all levels of glomerular filtration rate

   • Michael Rehling
   • Bente V. Nielsen
   • Theis Bacher

   Original article Pages: 1379 - 1384

5. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: Assessment with iodine-123-labelled beta-methyl-branched fatty acid

   • Junichi Taki
   • Kenichi Nakajima
   • Kinichi Hisada

   Original article Pages: 1385 - 1392

6. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin

   • Carlo Aprile
   • Gabriella Marinone
   • Giampaolo Merlini

   Original article Pages: 1393 - 1401

7. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report

   • Ren-Shyan Liu
   • Shin-Hwa Yeh
   • Liang-Chi Wu

   Original article Pages: 1402 - 1407

8. Does Dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?

   • Thomas Leitha
   • Marianne Gwechenberger
   • Susanne Falger-Banyai

   Short communication Pages: 1408 - 1410

9. Imaging of pulmonary disease in rheumatoid arthritis using J001X scintigraphy: Preliminary results

   • Philippe Goupille
   • Patrice Diot
   • Alain Le Pape

   Short communication Pages: 1411 - 1415

10. A miniaturized rapid paper chromatographic procedure for quality control of technetium-99m sestamibi

    • Mohan Patel
    • Samy Sadek
    • Azu Owunwanne

    Short communication Pages: 1416 - 1419

11. PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs)

    • G. -J. Meyer
    • S. L. Waters
    • B. Langström

    Occasional survey Pages: 1420 - 1432

12. Where are we with nuclear medicine in pediatrics?

    • Helen R. Nadel

    Review article Pages: 1433 - 1451

13. Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma

    • Adil M. AL-Nahhas
    • Pantelis Hjiyiannakis
    • Alan H. Horwich

    Case report Pages: 1453 - 1456

14. Effect of tissue heterogeneity on quantification in positron emission tomography

    • Jyrki T. Kuikka

    Letter to the editor Pages: 1457 - 1458

15. Book review

    • J. J. Broerse

    BookReview Pages: 1459 - 1460

16. Here in the USA

    • Manuel D. Cerqueira

    OriginalPaper Pages: 1461 - 1463

17. A window on Japan

    • Katsumi Tomiyoshi

    OriginalPaper Pages: 1465 - 1466

18. Certificate of fellowship of the european board of nuclear medicine

    • A. Bischof Delaloye

    Blue pages Pages: BP35 - BP36

19. Activities of the european school of nuclear medicine (ESNM)

    • W. Becker

    Blue pages Pages: BP37 - BP38

20. European school of nuclear medicine 3rd seminar

    Blue pages Pages: BP39 - BP39